Adicet Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	36.25	38.92	56.5	159.71	257.66	277.54
Short-Term Investments	101.35	119.61	119.81	-	-	-
Cash & Short-Term Investments	137.59	158.53	176.3	159.71	257.66	277.54
Cash Growth	-8.54%	-10.08%	10.39%	-38.01%	-7.17%	193.34%
Accounts Receivable	-	-	-	-	-	0.19
Other Current Assets	2.48	2.4	3.83	2.56	3.38	4.71
Total Current Assets	140.07	160.93	180.14	162.27	261.04	282.44
Net Property, Plant & Equipment	26.36	28.48	36.75	44.2	48.98	35
Goodwill	-	-	-	-	19.46	19.46
Other Long-Term Assets	2.95	2.95	3.33	0.82	1.21	2.04
Total Assets	169.38	192.36	220.22	207.3	330.69	338.94
Accounts Payable	2.93	4.74	4.83	2.63	4.4	3.26
Accrued Expenses	12.49	13.61	11.43	13.44	12.81	6.68
Current Portion of Leases	2.88	3.19	3.13	3.22	2.49	1.57
Unearned Revenue	-	-	-	-	-	4.81
Total Current Liabilities	18.3	21.53	19.39	19.29	19.71	16.32
Long-Term Leases	11.02	11.55	14.1	17.7	18.53	19.38
Other Long-Term Liabilities	-	0.06	0.12	0.13	0.11	0.12
Total Long-Term Liabilities	11.02	11.61	14.22	17.83	18.65	19.49
Total Liabilities	29.32	33.15	33.61	37.12	38.35	35.81
Common Stock	0	0.01	0.01	0	0	0
Additional Paid-in Capital	775.04	773.8	684.48	550.94	530.45	471.45
Accumulated Other Comprehensive Income	-0.04	0.1	0.02	-	-	-
Retained Earnings	-634.94	-614.7	-497.89	-380.77	-238.11	-168.32
Shareholders' Equity	140.07	159.21	186.61	170.18	292.34	303.13
Total Liabilities & Equity	169.38	192.36	220.22	207.3	330.69	338.94
Total Debt	13.9	14.74	17.23	20.92	21.02	20.94
Net Cash (Debt)	123.69	143.79	159.07	138.79	236.63	256.6
Net Cash Growth	-13.98%	-9.60%	14.61%	-41.35%	-7.78%	251.63%
Net Cash Per Share	15.22	20.87	28.97	51.59	92.16	132.64
Book Value	140.07	159.21	186.61	170.18	292.34	303.13
Book Value Per Share	17.24	23.10	33.98	63.26	113.86	156.70
Tangible Book Value	140.07	159.21	186.61	170.18	272.88	283.67
Tangible Book Value Per Share	17.24	23.10	33.98	63.26	106.28	146.63

SEC Filings: 10-K · 10-Q